‘Confusion’ Clogs Sunscreen TEA Proposals, ‘Radio Silence’ On NSURE Progress – Woodcock
This article was originally published in The Tan Sheet
At a CHPA conference in Washington, the CDER director elaborates on the center’s work on OTC monograph modernization and the NSURE initiative in addition to sunscreen ingredient TEAs. Use in foreign countries means only that a sunscreen ingredient is eligible to be proposed for FDA consideration, she says.
You may also be interested in...
When firms suggest submitting switch NDAs for “something that would be worth engaging on, we’re not going to tell you no,” says FDA nonprescription drug program chief Theresa Michele.
An NIH-funded study shows 92% of older consumers have chronic conditions, the primary target of FDA’s Nonprescription Safe Use Regulatory Expansion initiative to facilitate more Rx-to-OTC switches. The agency also extends the comment period for its initiative on making more ingredients available through the OTC monograph process.
White House, Democrat majority in Congress and likely next FTC chair support the agency wielding the authority, says advertising law attorney Holly Melton. Supreme Court, though, likely will rule in pending cases that a strict reading of an FTC regulation doesn’t grant monetary penalty authority.